Best Treatment Options for Keloids
The combination of intralesional bleomycin and triamcinolone acetonide is the most effective treatment for keloids, showing superior outcomes with 76% excellent response rate compared to other treatment modalities. 1
Treatment Algorithm Based on Keloid Size and Characteristics
For Small Keloids (<2 cm)
- First-line treatment: Intralesional triamcinolone acetonide (TAC) 10-40 mg/mL every 3-4 weeks 2
- If inadequate response after 3 sessions, add cryotherapy
- Second-line treatment: Combination therapy
For Larger or Resistant Keloids (>2 cm)
Efficacy of Treatment Options
The most recent high-quality evidence shows that the combination of intralesional bleomycin and triamcinolone acetonide provides:
- 76% excellent response rate
- Significant improvements in:
- Flattening of lesions
- Vancouver Scar Scale scores
- Lower recurrence rates
- Cosmetic appearance
- Reduction in movement restriction
- Decreased tenderness 1
This combination therapy is significantly more effective than the combination of 5-FU and triamcinolone acetonide, which showed only 50% excellent response rate 1.
Treatment Considerations and Precautions
- Anatomical location: Keloids on high-tension areas (chest, shoulders, back) are more resistant to treatment 2
- Patient factors: Darker skin types and family history of keloids are associated with higher recurrence rates 2
- Contraindications:
Additional Treatment Options
For cases resistant to first and second-line therapies:
- Surgical excision: Most effective when combined with adjuvant therapy to prevent recurrence 2
- Radiation therapy: For recalcitrant keloids 3
- Silicone sheeting: Can be used as an adjunct therapy 3
- Pulsed-dye laser: Recently shown to be effective for keloids 3
Important Clinical Pearls
- Begin treatment early for best results
- Combination therapy is more effective than monotherapy 3
- Treatment response is typically evident within the first 2 infiltrations 4
- Multiple treatment sessions are usually required due to high recurrence rates 2
- Patients should be counseled about realistic expectations given the challenging nature of keloid treatment 2
Emerging Therapies
While not yet first-line, promising newer treatments include:
- Amniotic membrane application for non-healing keloids 2
- Autologous serum or platelet-rich plasma for persistent cases 2
- Anti-hypertensive pharmaceuticals, calcineurin inhibitors, and mesenchymal stem cell therapy 5
The treatment of keloids remains challenging, but the combination of intralesional bleomycin and triamcinolone acetonide currently offers the best outcomes for reducing keloid size, improving symptoms, and preventing recurrence.